everolimus,pembrolizumab,lenvatinib,sunitinib
merck,pfizer,eisai
['thanks', 'clear trial', 'kcsm,(-skcsm)', 'rcc,(-irccs),(-srcc),(-urcc)']
thomas hutson, do, of joined us today at to share updates from the clear trial in arcc. thanks, dr hutson! head to our website for more coverage of #asco23: #kcsm #rcc 
Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.